In addition, the effect of C1730G was reversed from a protective effect (adjusted OR = 0.18, 95% CI = 0.15–0.22) to a risk effect with borderline significance (adjusted OR = 2.07, 95% CI = 1.02–4.20) after being conditionally adjusted by the other mutations.
← all excerpts
Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
1
—
—